1. Home
  2. NSRX vs VNRX Comparison

NSRX vs VNRX Comparison

Compare NSRX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.25

Market Cap

25.8M

Sector

Health Care

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.16

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSRX
VNRX
Founded
2019
N/A
Country
Israel
United States
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.8M
22.5M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
NSRX
VNRX
Price
$2.25
$0.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$19.67
$2.00
AVG Volume (30 Days)
176.1K
16.6M
Earning Date
03-25-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$479.89
Revenue Next Year
N/A
$538.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$1.98
$0.15
52 Week High
$9.99
$0.94

Technical Indicators

Market Signals
Indicator
NSRX
VNRX
Relative Strength Index (RSI) 36.03 34.76
Support Level $1.98 $0.15
Resistance Level $5.20 $0.27
Average True Range (ATR) 0.22 0.02
MACD 0.10 -0.00
Stochastic Oscillator 40.85 8.72

Price Performance

Historical Comparison
NSRX
VNRX

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: